Stock Analysis

Landstar System Full Year 2024 Earnings: In Line With Expectations

Published
NasdaqGS:LSTR

Landstar System (NASDAQ:LSTR) Full Year 2024 Results

Key Financial Results

  • Revenue: US$4.83b (down 9.0% from FY 2023).
  • Net income: US$195.9m (down 26% from FY 2023).
  • Profit margin: 4.1% (down from 5.0% in FY 2023). The decrease in margin was driven by lower revenue.
  • EPS: US$5.51 (down from US$7.36 in FY 2023).
NasdaqGS:LSTR Earnings and Revenue Growth January 31st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Landstar System Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

Looking ahead, revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Transportation industry in the US.

Performance of the American Transportation industry.

The company's shares are down 5.2% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 1 warning sign for Landstar System that you need to be mindful of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.